netFormulary NHS
Demonstration Formulary
 Search
 Results

Looking for Nivolumab found 18 matches

   


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA384: Nivolumab for treating advanced (unresectable or metastatic) melanoma (08.02.03)
link in drug section NICE TA400: Nivolumab in combination with ipilimumab for treating advanced melanoma (08.02.03)
link in drug section NICE TA417: Nivolumab for previously treated advanced renal cell carcinoma (08.02.03)
link in drug section NICE TA462: Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma (08.02.03)
link in drug section NICE TA483: Nivolumab for previously treated squamous non-small-cell lung cancer (08.02.03)
link in drug section NICE TA484: Nivolumab for previously treated non-squamous non-small-cell lung cancer (08.02.03)
link in drug section NICE TA490: Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (08.02.03)
link in drug section NICE TA530: Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy (08.02.03)
link in drug section NICE TA558: Nivolumab for adjuvant treatment of completely resected melanoma with lymph mode involvement or metastatic disease (08.02.03)
link in drug section NICE TA581: Nivolumab with ipilimumab for untreated advanced renal cell carcinoma (08.02.03)
link in drug section NICE TA655: Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy (08.02.03)
link in drug section NICE TA684: Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease (08.02.03)
link in drug section NICE TA707: Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer (08.02.03)
link in drug section NICE TA713: Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy (08.02.03)
link in drug section NICE TA716: Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency (08.02.03)
link in drug section NICE TA736: Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (08.02.03)
link in drug section NICE TA746: Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer (08.02.03)
link in drug section NICE TA780: Nivolumab with ipilimumab for untreated advanced renal cell carcinoma (08.02.03)


 
netFormulary